India Glucose Monitoring Devices Market By Product (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

The glucose monitoring devices market in India was valued at USD 366.53 Million in 2024 and is anticipated to reach USD 550.20 Million by 2030, with a CAGR of 7.08% during 2025-2030. 

The Glucose Monitoring Devices market includes the development, manufacturing, distribution, and sale of devices designed to measure and continuously monitor blood glucose levels. These devices are essential for managing diabetes, offering a range of options to meet the diverse needs of individuals. From traditional blood glucose meters, which require a finger prick for readings, to advanced continuous glucose monitoring (CGM) systems that provide real-time data, the market provides solutions for various preferences and lifestyles.

Key drivers of this market include the rising global prevalence of diabetes. As more people are diagnosed with the condition, the demand for accurate and reliable glucose monitoring devices has surged. Technological advancements have significantly improved these devices, enhancing their functionality and ease of use.

Increased awareness of early diabetes management has also contributed to market growth. Recognizing that proactive monitoring and control of blood glucose levels can improve quality of life, more individuals are prioritizing timely interventions. This shift has led to greater adoption of glucose monitoring devices as a key tool in effective diabetes management.

The Glucose Monitoring Devices market is dynamic and continuously evolving. As technology advances and awareness of diabetes management increases, the demand for innovative glucose monitoring solutions is expected to grow, further shaping this critical sector.

Key Market Drivers

Rising Prevalence of Diabetes in India

The growing prevalence of diabetes in India is significantly increasing the demand for glucose monitoring devices. With millions of individuals living with diabetes, India is often referred to as the "diabetes capital of the world." An estimated 77 million people over the age of 18 are affected by type 2 diabetes, with nearly 25 million at risk of developing the condition (pre-diabetics). Over 50% of these individuals remain unaware of their diabetic status, which can lead to severe complications if not diagnosed and treated promptly. The shift in lifestyle, including dietary habits and physical activity levels, has caused a surge in both type 1 and type 2 diabetes cases. As a result, there is a growing demand for reliable tools to monitor and manage blood glucose levels.

Awareness about diabetes and the importance of early detection is driving increased emphasis on self-monitoring. Proactive monitoring of blood glucose levels helps patients and healthcare providers make informed decisions about diet, medication, and lifestyle changes, improving disease management and preventing further complications.

Growth of the Aging Population

The aging population in India is also contributing to the rising demand for glucose monitoring devices. According to UNFPA, India’s elderly population (60 years and above) is currently 153 million, and it is projected to grow to 347 million by 2050. This demographic shift means that more individuals will need regular monitoring for chronic conditions like diabetes, as aging is a significant risk factor for developing type 2 diabetes. As people age, insulin sensitivity declines, making it crucial for older adults to monitor their blood glucose levels regularly.

Improved healthcare and living conditions have increased life expectancy, which means people are living longer with chronic conditions, including diabetes. Regular glucose monitoring plays an essential role in managing these conditions and maintaining a higher quality of life. Additionally, many older adults prefer to remain independent and live at home, and glucose monitoring devices allow them to manage their condition without frequent visits to healthcare facilities.

Technological Advancements in Glucose Monitoring

Technological advancements are reshaping the diabetes management landscape in India, making glucose monitoring more accurate, accessible, and convenient. Continuous Glucose Monitoring (CGM) systems have transformed diabetes management by providing real-time data on glucose fluctuations, allowing users to adjust insulin doses and lifestyle choices accordingly. The rise of CGMs is largely driven by the demand for better glycemic control.

In September 2023, India-based startup Bonatra introduced the Smart Ring X1, a wearable device that tracks heart rate, blood oxygen levels, sleep quality, and glucose levels, integrating with CGMs to generate a metabolic score. These technological innovations, which sync with smartphones and wearable devices, offer users the convenience of tracking glucose data and sharing it with healthcare providers and caregivers in real time.

Improvements in Healthcare Infrastructure

India's healthcare infrastructure improvements are also contributing to the increased demand for glucose monitoring devices. With over 1.6 lakh Sub-Centres, 31,882 Primary Health Centres, and 6,359 Community Health Centres as of March 31, 2023, access to diabetes screening and monitoring has expanded significantly, driving demand for monitoring devices. The government’s efforts to strengthen primary healthcare pathways, such as the Ayushman Arogya Mandirs, have increased the availability of diabetes care and follow-up services, boosting the uptake of glucose monitoring devices.

Government initiatives like the Union Health Ministry's 75/25 initiative aim to screen and manage 75 million people with hypertension and diabetes by 2025, which will increase demand for glucose monitoring devices. Additionally, the Ayushman Bharat Digital Mission, with over 79.75 crore ABHA IDs and 65.34 crore electronic health records linked, has facilitated digital integration into healthcare delivery, supporting regular follow-ups and monitoring adherence..

Key Market Challenges

High Cost of Glucose Monitoring Devices

In India, many individuals, especially those from low-income backgrounds, face challenges in affording the upfront costs of glucose monitoring devices. The recurring expenses for test strips and sensors can also strain finances over time. Health insurance coverage for these devices and related supplies remains limited, meaning individuals often have to pay the full cost out of pocket, making them less accessible to a significant portion of the population.

Healthcare providers, including hospitals and clinics, often face budget constraints. The high cost of glucose monitoring devices can deter these facilities from investing in essential equipment, limiting access to comprehensive diabetes care. Rural and underserved areas may have even more limited access to healthcare services and resources. The high cost of glucose monitoring devices makes them less likely to be available or affordable in these regions, leaving individuals with fewer options for diabetes management. This financial barrier can discourage people from regularly monitoring their blood glucose levels, leading to poor adherence to diabetes management plans, suboptimal disease control, and higher healthcare costs due to complications.

Limited Availability in Remote and Rural Areas

Remote and rural areas in India often have limited access to healthcare facilities and medical supplies, including glucose monitoring devices such as glucometers and test strips. This geographical disparity reduces demand for these devices due to their scarcity. Even when glucose monitoring devices are available in urban centers, transportation barriers can hinder their distribution to rural areas. The logistical challenges and high costs of transporting these devices further limit their availability.

In these areas, individuals may have limited awareness about the importance of blood glucose monitoring in diabetes management. Without proper education and awareness campaigns, there may be little demand for these devices as people may not fully understand their significance. Additionally, in many rural regions with lower income levels, the affordability of glucose monitoring devices remains a major hurdle. Even if these devices were more readily available, the high cost would still prevent many individuals from purchasing them, reducing demand. The lack of well-developed healthcare infrastructure, along with a shortage of trained healthcare professionals in rural areas, further complicates access to glucose monitoring devices. Without the necessary support from healthcare providers, individuals may be less inclined to seek out these devices, further hindering diabetes management efforts.

Key Market Trends

Growth in the Use of Non-Invasive Glucose Monitoring Devices

The demand for non-invasive glucose monitoring devices is growing significantly in India, where nearly 8.7% of the population aged 20-70 has diabetes. These devices, which measure blood glucose levels without the need for skin pricking, are gaining attention for their convenience and reduced discomfort.

Non-invasive devices, like a new sensor developed by researchers at MNNIT Prayagraj, offer a painless alternative to traditional finger-stick methods. This improved comfort encourages individuals with diabetes to monitor their blood glucose levels more frequently, leading to better disease management. Non-invasive devices are often user-friendly and require minimal training, making them more accessible to a broader population.

The increasing emphasis on preventive healthcare, supported by initiatives like a government program to screen 75 million individuals for diabetes by 2025, has spurred interest in non-invasive devices. People are using these tools not just for diabetes management but also for early detection and lifestyle adjustments to prevent diabetes onset. Non-invasive monitoring devices, including Continuous Glucose Monitoring (CGM) systems, provide real-time insights into glucose patterns, empowering individuals to take control of their health. The rise of digital health tools, such as India’s mDiabetes program with 8.6 million sign-ups, and telemedicine platforms that allow remote monitoring, further supports the adoption of these devices.

As the use of non-invasive glucose monitoring devices continues to grow, demand in India is likely to increase further. These devices are seen as "game-changers" for diabetes management, offering an attractive alternative that contributes to improved disease control and better health outcomes.

Increased Use of Smart Glucometers

Smart glucometers, which allow users to wirelessly transfer blood glucose data to smartphones or other devices, are also gaining popularity in India, where more than 100 million people live with diabetes. This connectivity provides a seamless way to track and manage glucose levels through apps like BeatO, which has over 2.5 million downloads, and mySugr, with over 1 million downloads. A real-world study in India using the mySugr app found that users lowered their average HbA1c from 8.8 to 7.5 over three months. This instant access to critical information helps individuals with diabetes make timely adjustments to their treatment plans.

Smart glucometers enable data sharing with healthcare providers, caregivers, and family members, facilitating remote monitoring and timely interventions when necessary. This feature is especially valuable in a country as large as India, where initiatives like the Research Society for the Study of Diabetes in India's rural outreach program aim to distribute glucometers across 1,000 villages. Many smart glucometer apps also include features to track medication schedules, diet, and exercise routines. Users of the BeatO platform, for example, have reported an average reduction of 63 mg/dL in fasting blood sugar levels.

The user-friendly interfaces of smart glucometers and their accompanying apps make them accessible to a wide range of users, including those who may not be tech-savvy. In a comparative analysis, the government-promoted Madhumeh Setu app received a quality score of 4.05, competing with established apps like BeatO (4.12). This ease of use encourages more individuals to adopt these devices for regular monitoring. With continuous technological advancements, such as the upcoming June 2025 launch of Tracky, India’s first Bluetooth-enabled Continuous Glucose Monitor (CGM), these solutions are becoming increasingly appealing to individuals seeking effective and convenient diabetes management.

Segmental Insights

Product Insights

Continuous glucose monitoring (CGM) devices are expected to dominate the market over self-monitoring of blood glucose (SMBG) devices. CGM devices provide real-time glucose readings, allowing users to take immediate action based on accurate data. This eliminates the need for frequent finger pricking, a downside of SMBG devices, making CGM a more convenient and user-friendly option for individuals managing diabetes.

The continuous tracking feature of CGM devices offers valuable insights into glucose patterns and trends, improving glucose management. This comprehensive data helps users make informed decisions about their diet, exercise, and medication, leading to more effective diabetes management and preventing potential complications. By leveraging the information provided by CGM devices, individuals can proactively work towards optimal glucose control and overall well-being.

Application Insights

The rising prevalence of Type 2 diabetes is expected to significantly impact the demand for glucose monitoring devices in India. This form of diabetes, often linked to lifestyle factors such as diet and physical activity, is rapidly increasing due to changes in the population's eating habits and lifestyles. This shift in health patterns has created a critical need for effective management and monitoring of Type 2 diabetes, driving the growth of the glucose monitoring device market.

As healthcare providers and individuals work to address this health challenge, demand for advanced, reliable glucose monitoring devices is expected to rise, contributing to improved diabetes care in India..

Download Free Sample Report

Regional Insights

The Western region of India, particularly in states like Maharashtra and Gujarat, is expected to exert significant influence on the Glucose Monitoring Devices Market. This can be attributed to several factors including a higher prevalence of diabetes, a more developed healthcare infrastructure, and an increasing awareness of the importance of self-monitoring glucose devices among the population in these states. As a result, these states are likely to see greater adoption of glucose monitoring devices, leading to substantial growth in the regional market.

Also, the Western region of India has been at the forefront of technological advancements in healthcare, with major cities like Mumbai and Ahmedabad serving as hubs for medical research and innovation. This has paved the way for cutting-edge glucose monitoring devices that offer improved accuracy, convenience, and ease of use.

Moreover, state-level initiatives to promote diabetes management and control have further contributed to the growth of the glucose monitoring devices market in this region. These initiatives include awareness campaigns, subsidized healthcare services, and the establishment of specialized diabetes care centers. With the rising prevalence of diabetes and the increasing focus on proactive healthcare management, the demand for glucose monitoring devices is expected to soar in the Western region of India. This presents a lucrative opportunity for manufacturers and suppliers to cater to the needs of a large and growing consumer base.

Recent Developments

• In September 2025, Abbott highlighted its push toward broader CGM adoption via partnerships and a more “connected care” ecosystem (patients/caregivers/HCP workflows), while also noting the Libre 2 Plus extends wear time versus earlier Libre sensors.
• In August 2025, Abbott launched the FreeStyle Libre 2 Plus sensor in India, positioned to provide automatic glucose readings every minute to a compatible smartphone and optional high/low glucose alarms. Abbott stated it is available across India for adults and children (including for gestational diabetes use).
• In June 2025, at the 12th Hello Diabetes Academia in Nagpur, experts from the Research Society for the Study of Diabetes in India (RSSDI) announced a rural outreach targeting 1,000 villages, including the distribution of glucometers, BP monitors, and advocating for continuous glucose monitoring (CGM) to fine‑tune insulin treatment. 
• In June 2025, to address one of India’s most critical health challenges, Tracky, an innovative healthtech venture by DrStore Healthcare Services, officially launched its flagship product — the country’s first Bluetooth-enabled Continuous Glucose Monitor (CGM). This cutting-edge device combines advanced sensor technology with a Bluetooth-enabled transmitter and a mobile application, offering a future-ready solution for glucose monitoring and management. The launch underscores Tracky’s commitment to innovation, affordability, and accessibility for the Indian population.
• In April 2025, Ambrosia, a global leader in real-time health monitoring, introduced India’s first 24x7 real-time glucose and stress monitoring service, following its widespread adoption in the United States and Europe. This pioneering service integrates state-of-the-art wearable sensor technology, AI-driven analytics, and remote monitoring to deliver continuous health insights, empowering individuals to proactively manage their well-being.

Key Market Players

• Roche Diagnostics India Pvt. Ltd.
• Abbott India Ltd.
• Becton Dickinson Pvt. Ltd.
• ARKRAY Healthcare Pvt. Ltd.
• B. Braun Medical (India) Pvt. Ltd.
• Johnson & Johnson Ltd.
• India Medtronic Private Ltd.
• Pulsatom Health Care Pvt. Ltd.
• Bio-Rad laboratories India Pvt.Ltd.

Report Scope:

In this report, the India Glucose Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Glucose Monitoring Devices Market, By Product:

o   Self-Monitoring Glucose Devices

o   Continuous Glucose Monitoring Devices

• India Glucose Monitoring Devices Market, By Application:

o   Type 1 Diabetes

o   Type 2 Diabetes

o   Gestational Diabetes

• India Glucose Monitoring Devices Market, By End User:

o   Home Care Settings

o   Hospital

o   Others

• India Glucose Monitoring Devices Market, By Region:

o   North

o   South

o   West

o   East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Glucose Monitoring Devices Market.

Available Customizations:

India Glucose Monitoring Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).